Εμφάνιση απλής εγγραφής

dc.creatorTsouloufi T.K., Theodorou K., Day M.J., Oikonomidis I.L., Kasabalis D., Mylonakis M.E., Saridomichelakis M.N., Kritsepi-Konstantinou M., Soubasis N.en
dc.date.accessioned2023-01-31T10:19:40Z
dc.date.available2023-01-31T10:19:40Z
dc.date.issued2022
dc.identifier10.1177/10406387221099030
dc.identifier.issn10406387
dc.identifier.urihttp://hdl.handle.net/11615/80170
dc.description.abstractDogs with infectious arthritis may occasionally exhibit positive serum antinuclear antibody (ANA) and rheumatoid factor (RF) titers; however, relevant data are sparse for arthritis secondary to canine leishmaniosis (CanL) caused by Leishmania infantum. We determined the prevalence of positive serum ANA and RF titers in dogs with arthritis secondary to CanL. Blood samples from adult, client-owned dogs with purulent arthritis secondary to CanL, without any comorbidities, were collected for diagnostic purposes. Serum ANA titers were measured by immunoperoxidase test and RF titers by the Rose–Waaler latex test. Twelve of 23 dogs enrolled prospectively in our study had clinical arthritis, and 11 of 23 had subclinical arthritis. Based on LeishVet clinical staging, 7 dogs had clinical stage II disease, 11 had clinical stage III disease, and 5 had stage IV. None of the 23 dogs was seropositive for ANA; 3 of 23 were positive for RF. ANA and/or RF seropositivity, in dogs with CanL-associated arthritis, appears to be weak, if present at all. Based on our results, positive serum ANA and RF titers should not be expected in dogs with arthritis secondary to CanL. © 2022 The Author(s).en
dc.language.isoenen
dc.sourceJournal of Veterinary Diagnostic Investigationen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85131521863&doi=10.1177%2f10406387221099030&partnerID=40&md5=8b06bfe8fbfb06b39b7d36610c2a7159
dc.subjectacepromazineen
dc.subjectantinuclear antibodyen
dc.subjectdiaminobenzidineen
dc.subjecthistoneen
dc.subjectimmunoglobulin Gen
dc.subjectimmunoglobulin Men
dc.subjectisofluraneen
dc.subjectmorphineen
dc.subjectperoxidaseen
dc.subjectrheumatoid factoren
dc.subjectribonucleoproteinen
dc.subjectantinuclear antibodyen
dc.subjectrheumatoid factoren
dc.subjectadulten
dc.subjectanaplasmosisen
dc.subjectanimal experimenten
dc.subjectanimal lamenessen
dc.subjectanimal tissueen
dc.subjectantibody titeren
dc.subjectarthritisen
dc.subjectArticleen
dc.subjectblood samplingen
dc.subjectBorrelia infectionen
dc.subjectcancer stagingen
dc.subjectcomorbidityen
dc.subjectcontrolled studyen
dc.subjectdirofilariasisen
dc.subjectdogen
dc.subjectechocardiographyen
dc.subjectechographyen
dc.subjectenzyme linked immunosorbent assayen
dc.subjectfemaleen
dc.subjectHEp-2 cell lineen
dc.subjecthuman monocytic ehrlichiosisen
dc.subjectimmunofluorescence assayen
dc.subjectLeishmania infantumen
dc.subjectleishmaniasisen
dc.subjectlymphocyteen
dc.subjectmaleen
dc.subjectmonarthritisen
dc.subjectmononuclear cellen
dc.subjectneutrophilen
dc.subjectnonhumanen
dc.subjectprevalenceen
dc.subjectprospective studyen
dc.subjectsynovial fluiden
dc.subjectsynoviumen
dc.subjectsystemic lupus erythematosusen
dc.subjectthorax radiographyen
dc.subjectvaccinationen
dc.subjectvector borne diseaseen
dc.subjectanimalen
dc.subjectcomplicationen
dc.subjectdogen
dc.subjectdog diseaseen
dc.subjectprevalenceen
dc.subjectveterinary medicineen
dc.subjectvisceral leishmaniasisen
dc.subjectAnimalsen
dc.subjectAntibodies, Antinuclearen
dc.subjectArthritisen
dc.subjectDog Diseasesen
dc.subjectDogsen
dc.subjectLeishmania infantumen
dc.subjectLeishmaniasisen
dc.subjectLeishmaniasis, Visceralen
dc.subjectPrevalenceen
dc.subjectRheumatoid Factoren
dc.subjectSAGE Publications Inc.en
dc.titlePrevalence of antinuclear antibodies and rheumatoid factor titers in dogs with arthritis secondary to leishmaniosis (Leishmania infantum)en
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής